Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect-Reference-Cited by-同舟云学术

Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect

Published:2017-09-25 Issue:28 Volume:24 Page:
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Antonuzzo Lorenzo¹,Lunghi Alice²,Petreni Paolo²,Brugia Marco²,Laffi Alice²,Giommoni Elisa²,Mela Marinella M.²,Mazzoni Francesca²,Balestri Vanni³,Costanzo Francesco Di²

Affiliation:

1. Medical Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139 Firenze, Italy

2. Azienda Ospedaliero-Universitaria Careggi, Medical Oncology Unit, Largo Brambilla 3, 50139 Firenze, Italy

3. Azienda Ospedaliero-Universitaria Careggi, Unit of Special Care Dentistry, Largo Brambilla 3, 50139 Firenze, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could MRONJ Be Related to Osimertinib Monotherapy in Lung Cancer Patients after Denosumab Suspension?;Healthcare;2024-02-10

2. Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer;International Journal of Molecular Sciences;2023-03-19

3. Medication‐related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients;Oral Diseases;2022-12-15

4. Oral Side Effects in Patients with Metastatic Renal Cell Carcinoma Receiving the Antiangiogenic Agent Pazopanib—Report of Three Cases;Dentistry Journal;2022-12-08

5. Organic Bone Matrix Component Type I and V Collagen Are Not Destructed in Bisphosphonate-Associated Osteonecrosis of the Jaws;Medicina;2022-11-21